Search

Your search keyword '"Ten Cate, Hugo"' showing total 112 results

Search Constraints

Start Over You searched for: Author "Ten Cate, Hugo" Remove constraint Author: "Ten Cate, Hugo" Publisher elsevier bv Remove constraint Publisher: elsevier bv
112 results on '"Ten Cate, Hugo"'

Search Results

1. Altered whole blood thrombin generation and hyperresponsive platelets in patients with pancreatic cancer

5. Outcomes of Oral Anticoagulation in Atrial Fibrillation Patients With or Without Comorbid Vascular Disease: Insights From the GARFIELD-AF Registry

7. Unsupervised clustering of venous thromboembolism patients by clinical features at presentation identifies novel endotypes that improve prognostic stratification

8. Applications of rotational thromboelastometry in heparin monitoring in critical COVID-19 disease: Observations in the Maastricht Intensive Care COVID cohort

10. Tissue factor expression in monocyte subsets during human immunothrombosis, endotoxemia and sepsis

14. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

15. Population-Wide Persistent Hemostatic Changes After Vaccination With ChAdOx1-S

16. Subtype-specific plasma signatures of platelet-related protein releasate in acute pulmonary embolism

17. Lower levels of vWF are associated with lower risk of cardiovascular disease

18. Unequal prescription of anticoagulants among females and males with atrial fibrillation and similar stroke risk: Should we omit sex category from the CHA2DS2-VASc score?

21. Variation of platelet function in clinical phenotypes of acute venous thromboembolism – Results from the GMP‐VTE project

22. 36-Month Clinical Outcomes of Patients with Venous Thromboembolism: GARFIELD-VTE

24. ChAdOx1 vaccination, blood coagulation, and inflammation: No effect on coagulation but increased interleukin‐6

26. Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study

27. B-PO01-019 COAGULATION POTENTIAL, ELECTROPHYSIOLOGICAL CHARACTERISTICS AND STRUCTURAL REMODELING DUE TO ATRIAL FIBRILLATION IN YOUNG AND AGED GOATS

29. Hemostasis and fibrinolysis in COVID‐19 survivors 6 months after intensive care unit discharge

30. Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin

33. Recommendations for the measurement of thrombin generation: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies

39. Impact of different anticoagulation management strategies on outcomes in atrial fibrillation: Dutch and Belgian results from the GARFIELD‐AF registry

40. Outcome of intracranial bleeding managed with prothrombin complex concentrate in patients on direct factor Xa inhibitors or vitamin K antagonists

41. The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: A three-setting comparison

42. Comprehensive platelet phenotyping supports the role of platelets in the pathogenesis of acute venous thromboembolism – results from clinical observation studies

43. Acute exacerbations of COPD are associated with a prothrombotic state through platelet-monocyte complexes, endothelial activation and increased thrombin generation

44. Underlying disorders of disseminated intravascular coagulation: Communication from the ISTH SSC Subcommittees on Disseminated Intravascular Coagulation and Perioperative and Critical Care Thrombosis and Hemostasis

47. Anticoagulation in thrombocytopenic patients with hematological malignancy: A multinational clinical vignette-based experiment

49. Emergencies on direct oral anticoagulants: Management, outcomes, and laboratory effects of prothrombin complex concentrate

50. Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry

Catalog

Books, media, physical & digital resources